Position in GPCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$56,635,000
-$25,086,250 QoQ
Shares Held
1,175,000
0.0% QoQ
Ownership
0.551%
of shares outstanding
% of Portfolio
4.29%
of 13F equity value
Holder Rank
#15
of 196 holders
Holding Since
Mar 2023
13 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GPCR Over Time
Shares Held
Position Value (USD)
Derivatives in GPCR
reported options exposure · as of Dec 31, 2023CallValue
$1,019,000
CallShares
25,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Casdin Capital, LLC holds $705,487,766 across 26 Biotechnology names. GPCR ranks #3 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,577,333 | $250,645,634 | |
| 2 | RLAY |
Relay Therapeutics, Inc.
|
14,418,574 | $143,464,811 | |
| 3 | GPCR |
Structure Therapeutics Inc.
This page
|
1,175,000 | $56,635,000 | |
| 4 | DNLI |
Denali Therapeutics Inc.
|
1,840,000 | $35,328,000 | |
| 5 | BEAM |
Beam Therapeutics Inc.
|
1,350,000 | $32,170,500 | |
| 6 | NGNE |
Neurogene Inc.
|
1,420,361 | $28,634,477 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
75,000 | $24,815,250 | |
| 8 | MAZE |
Maze Therapeutics, Inc.
|
758,857 | $22,651,881 |
All Filings in GPCR
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $56,635,000 | 1,175,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $81,721,250 | 1,175,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $43,540,000 | 1,555,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $25,406,500 | 1,225,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $12,117,000 | 700,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $18,984,000 | 700,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $30,723,000 | 700,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $27,489,000 | 700,000 | Shares | Sole | 2024-10-18 | |
| 2024-03-31 | $47,868,919 | 1,116,867 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,019,000 | 25,000 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $44,504,498 | 1,091,867 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $63,436,729 | 1,258,166 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $41,445,996 | 997,017 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $16,106,234 | 677,017 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||